Pharmaceutical Quality Systems (Chapter 1of Eudralex) became effective on 31st January 2013. The requirement for utilising Quality Risk Management is also becoming even more apparent and requires integration into the Quality culture. There is also a greater emphasis on evaluating the effectiveness of the Pharmaceutical Quality System and realising a culture of Continuous Improvement as well as compliance.
With the ever-growing need to constantly evaluate the effectiveness of our Quality Management System(QMS) and develop a Continuous Improvement Quality culture, there has never been a better time to review how we are performing this. Having a background in areas such as Organisational Development and Quality enables GxPpro to not only help you to review how effective your QMS is at managing quality but also to develop quality objectives and KPIs which are aligned to your business objectives. Just as important is communication and visibility of these metrics to the whole organisation as well as the involvement of individuals and teams in the development and attainment of those KPIs. How you then align the achievement of these objectives and KPIs with your pay and reward strategy will also have a significant impact on the outcomes.
If you would like to discuss this further, then please contact us and we will be only too pleased to help.
We also offer several training courses (such as Quality Risk Management), which may be of interest to you.
Further information can be found on our training page.
Train the trainer 2 day Nove 2011